Perturbations of lipid metabolism indexed by lipidomic biomarkers

Metabolites

Volumn 2, Issue 1, 2012, Pages

  Lamaziere, Antonin ^a   Wolf, Claude ^a,c   Quinn, Peter J ^b  

^a INSERM   (France)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Laboratory of Mass Spectrometry   (France)

Author keywords

Biomarkers; Biomedical lipidomics; Pharmacology

Indexed keywords

ACYLGLYCEROL; BIOLOGICAL MARKER; CHOLESTEROL; ESSENTIAL FATTY ACID; LIPOPROTEIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; PALMITOLEIC ACID; PHOSPHATIDYLCHOLINE; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

BIOLOGY; CLINICAL TRIAL (TOPIC); DYSLIPIDEMIA; FATTY LIVER; HEPATITIS C; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; LIPID COMPOSITION; LIPID METABOLISM; LIPID STORAGE; LIPIDOMICS; LIPOGENESIS; LIPOTOXICITY; LIVER FUNCTION; MASS FRAGMENTOGRAPHY; MEDICAL RESEARCH; METABOLIC DISORDER; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; NONHUMAN; OVARY POLYCYSTIC DISEASE; REVIEW;

EID: 84905822174     PISSN: None     EISSN: 22181989     Source Type: Journal    
DOI: 10.3390/metabo2010001     Document Type: Review

References (42)

1. Lei, Z.; Huhman, D.V.; Sumner, L.W. Mass Spectrometry Strategies in Metabolomics. J. Biol. Chem. 2011, 286, 25435-25442.
2. Schwudke, D.; Schuhmann, K.; Herzog, R.; Bornstein, S.R.; Shevchenko, A. Shotgun Lipidomics on High Resolution Mass Spectrometers. Cold Spring Harbor Perspective. Biol. 2011, 3, doi: 10.1101/cshperspect.a004614
3. Kanehisa, M.; Goto, S.; Furumichi, M.; Tanabe, M.; Hirakawa, M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010, 38, D355-D360.
4. Quehenberger, O.; Armando, A.M.; Brown, A.H.; Milne, S.B.; Myers, D.S.; Merrill, A.H.; Bandyopadhyay, S.; Jones, K.N.; Kelly, S.; Shaner, R.L.; et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 2010, 51, 3299-3305.
5. Wiest, M.M.; Watkins, S.M. Biomarker discovery using high-dimensional lipid analysis. Curr. Opin. Lipidol. 2007, 18, 181-186.
6. Donnelly, K.L.; Smith, C.I.; Schwarzenberg, S.J.; Jessurun, J.; Boldt, M.D.; Parks, E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 2005, 115, 1343-1351.
7. Mazer, N.A.; Carey, M.C. Mathematical model of biliary lipid secretion-A quantitative analysis of physiological and biochemical data from man and other species. J. Lipid Res. 1984, 25, 932-953.
8. Garcia-Monzon, C.; Lo Iacono, O.; Mayoral, R.; Gonzalez-Rodriguez, A.; Miquilena-Colina, M.E.; Lozano-Rodriguez, T.; Garcia-Pozo, L.; Vargas-Castrillon, J.; Casado, M.; Bosca, L.; Valverde, A.M.; et al. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C. J. Hepatol. 2011, 54, 142-152.
9. Zhang, W.; Kudo, H.; Kawai, K.; Fujisaka, S.; Usui, I.; Sugiyama, T.; Tsukada, K.; Chen, N.; Takahara, T. Tumor necrosis factor-alpha accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease. Biochem. Biophys. Res. Commun. 2010, 391, 1731-1736.
10. Ibrahim, S.H.; Kohli, R.; Gores, G.J. Mechanisms of Lipotoxicity in NAFLD and Clinical Implications. J. Pediat. Gastroenterol. Nutr. 2011, 53, 131-140.
11. Wree, A.; Kahraman, A.; Gerken, G.; Canbay, A. Obesity Affects the Liver-The Link between Adipocytes and Hepatocytes. Digestion 2011, 83, 124-133.
12. Puri, P.; Wiest, M.M.; Cheung, O.; Mirshahi, F.; Sargeant, C.; Min, H.-K.; Contos, M.J.; Sterling, R.K.; Fuchs, M.; Zhou, H.; et al. The Plasma Lipidomic Signature of Nonalcoholic Steatohepatitis. Hepatology 2009, 50, 1827-1838.
13. Hashimoto, E.; Tokushige, K. Prevalence, gender, ethnic variations, and prognosis of NASH. J. Gastroenterol. 2011, 46, 63-69.
14. Serfaty, L.; Lemoine, M. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. Diabetes Metab. 2008, 34, 634-637.
15. Bellentani, S.; Saccoccio, G.; Masutti, F.; Croce, L.S.; Brandi, G.; Sasso, F.; Cristanini, G.; Tiribelli, C. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann. Int. Med. 2000, 132, 112-117.
16. Meikle, P.J.; Christopher, M.J. Lipidomics is providing new insight into the metabolic syndrome and its sequelae. Curr. Opin. Lipidol. 2011, 22, 210-215.
17. Jamjute, P.; Ahmad, A.; Ghosh, T.; Banfield, P. Liver function test and pregnancy. J. Matern. Fetal Neonatal Med. 2009, 22, 274-283.
18. Boullart, A.C.I.; de Graaf, J.; Stalenhoef, A.F. Serum triglycerides and risk of cardiovascular disease. Biochim. Biophys. Acta 2011, doi:10.1016/j.bbalip.2011.10.002.
19. Debois, D.; Bralet, M.-P.; Le Naour, F.; Brunelle, A.; Laprevote, O. In situ lipidomic analysis of nonalcoholic fatty liver by cluster TOF-SIMS imaging. Anal. Chem. 2009, 81, 2823-2831.
20. Cao, J.; Zhou, Y.; Peng, H.; Huang, X.; Stahler, S.; Suri, V.; Qadri, A.; Gareski, T.; Jones, J.; Hahm, S.; et al. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases. J. Biol. Chem. 2011, doi:10.1074/jbc.M111.245456.
21. Cole, L.K.; Vance, J.E.; Vance, D.E. Phosphatidylcholine biosynthesis and lipoprotein metabolism. Biochim. Biophys. Acta 2011, doi:10.1016/j.bbalip.2011.09.009.
22. Zeisel, S.H. Gene response elements, genetic polymorphisms and epigenetics influence the human dietary requirement for choline. Iubmb. Life 2007, 59, 380-387.
23. Leitch, C.A.; Jones, P.J.H. Measurement of human lipogenesis using deuterium incorporation. J. Lipid Res. 1993, 34, 157-163.
24. Perez-Echarri, N.; Perez-Matute, P.; Marcos-Gomez, B.; Marti, A.; Alfredo Martinez, J.; Moreno-Allaga, M.J. Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats. J. Nutr. Biochem. 2009, 20, 705-714.
25. Puri, P.; Baillie, R.A.; Wiest, M.M.; Mirshahi, F.; Choudhury, J.; Cheung, O.; Sargeant, C.; Contos, M.J.; Sanyal, A.J. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007, 46, 1081-1090.
26. Liang, F.; Kume, S.; Koya, D. SIRT1 and insulin resistance. Nat. Rev. Endocrinol. 2009, 5, 367-373.
27. Antonio Chavez, J.; Summers, S.A. Lipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanisms. Biochim. Et Biophys. Acta-Mol. Cell Biol. Lipids 2010, 1801, 252-265.
28. Das, S.; Behera, M.K.; Misra, S.; Baliarsihna, A.K. beta-Cell function and insulin resistance in pregnancy and their relation to fetal development. Metab. Syndr. Relat. Disord. 2010, 8, 25-31.
29. Skrzypski, J.; Bellenger, S.; Bellenger, J.; Sinclair, A.; Poisson, J.-P.; Tessier, C.; Rialland, M.; Narce, M. Revisiting delta-6 desaturase regulation by C18 unsaturated fatty acids, depending on the nutritional status. Biochimie 2009, 91, 1443-1449.
30. Bartenschlager, R.; Penin, F.; Lohmann, V.; Andre, P., Assembly of infectious hepatitis C virus particles. Trends Microbiol. 2011, 19, 95-103.
31. Stepanova, M.; Rafiq, N.; Younossi, Z.M. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: A population-based study. Gut 2010, 59, 1410-1415.
32. Syed, G.H.; Amako, Y.; Siddiqui, A. Hepatitis C virus hijacks host lipid metabolism. Trends Endocrinol. Metab. 2010, 21, 33-40.
33. Bernsmeier, C.; Heim, M.H. Insulin resistance in chronic hepatitis C: Mechanisms and clinical relevance. Swiss Med. Weekly 2009, 139, 678-684.
34. Aragones, G.; Alonso-Villaverde, C.; Oliveras-Ferraros, C.; Beltran-Debon, R.; Rull, A.; Rodriguez-Sanabria, F.; Camps, J.; Vazquez Martin, A.; Menendez, J.A.; Joven, J. Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: Evidence for a novel indicator of viral infection. BMC Gastroenterol. 2010, 10, 92.
35. Lima-Cabello, E.; Garcia-Mediavilla, M.V.; Miquilena-Colina, M.E.; Vargas-Castrillon, J.; Lozano-Rodriguez, T.; Fernandez-Bermejo, M.; Olcoz, J.L.; Gonzalez-Gallego, J.; Garcia-Monzon, C.; Sanchez-Campos, S. Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C. Clin. Sci. 2011, 120, 239-250.
36. Banaszewska, B.; Pawelczyk, L.; Spaczynski, R.Z.; Duleba, A.J. Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment. J. Clin. Endocrinol. Metab. 2011, 96, 3493-3501.
37. Cress, A.; Banaszewska, B.; Pawelczyk, L.; Spaczynski, R.Z.; Duleba, A.J. A Combination of simvastatin and metformin reduces elevated levels of cytokines in women with PCOS. Endocrine Rev. 2010, 31, 1.
38. Wolf, C.; Quinn, P.J. Lipidomics in Diagnosis of lipidoses. Sub Cell. Biochem. 2008, 567-588.
39. Wolf, C.; Quinn, P.J. Lipidomics: Practical aspects and applications. Prog. Lipid Res. 2008, 47, 15-36.
40. Muhlhausler, B.S.; Cook-Johnson, R.; James, M.; Miljkovic, D.; Duthoit, E.; Gibson, R. Opposing effects of omega-3 and omega-6 long chain polyunsaturated Fatty acids on the expression of lipogenic genes in omental and retroperitoneal adipose depots in the rat. J. Nutr. Metab. 2010, doi:10.1155/2010/927836.
41. DeFina, L.F.; Marcoux, L.G.; Devers, S.M.; Cleaver, J.P.; Willis, B.L. Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. Am. J. Clin. Nutr. 2011, 93, 455-462.
42. Guillou, H.; Zadravec, D.; Martin, P.G.P.; Jacobsson, A. The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog. Lipid Res. 2010, 49, 186-199.